A sales partner offered a ray of hope that this company couldn't for itself.

2026 could be a big year for this company.

Researchers developed a CRISPR-based system that spreads through bacterial populations to disable antibiotic resistance genes ...

Sales of Casgevy, a gene-edited treatment developed with CRISPR Therapeutics, more than tripled compared to the third quarter, a performance analysts saw as a bright spot in Vertex's report.

A novel CRISPR-based technology can spread within bacterial populations to eliminate antibiotic resistance.

With a shared purpose, we can realize the true promise of CRISPR and improve healthcare, providing hope to more patients with ...

Active Genetics (Pro-AG) exploits a naturally created bacterial mating tunnel between cells to inactivate antibiotic resistance.

ZUG, Switzerland and BOSTON, Feb. 12, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today reported financial ...

Add Yahoo as a preferred source to see more of our stories on Google. Stanford researchers have developed CRISPR-GPT, an AI-powered copilot that guides gene-editing experiments. (CREDIT: Shutterstock) ...

A new CRISPR-powered light sensor can detect the faintest whispers of cancer in a single drop of blood.

VedaBio, a pioneering biotechnology company transforming molecular detection, today announced a non-exclusive license agreement with Mammoth Biosciences, Inc. for the use of select CRISPR-based ...

Researchers used CRISPR gene editing to selectively kill cancer cells with amplified oncogenes. In animal and cellular models ...